Global Travelers Vaccines Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
Description
According to our (Global Info Research) latest study, the global Travelers Vaccines market size was valued at US$ 4091 million in 2024 and is forecast to a readjusted size of USD 7241 million by 2031 with a CAGR of 8.6% during review period.
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body"s immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
Travelers are at increased risk for several infections, including familiar infections such as measles that are widely distributed but more common in developing countries. Travelers Vaccines can markedly decrease the risk for many of these infections and are an important part of pretravel preparation.
In this report, the travelers vaccines mainly covers vaccine for hepatitis A, hepatitis B, rabies, typhoid fever, yellow fever, Japanese encephalitis, meningococcal meningitis, cholera, etc.
Merck, GlaxoSmithKline and Sanofi Pasteur are the main manufacturers in the vaccine market, with a market share of more than 60% and a high degree of market concentration. North America and Europe are the main production regions, with market share of more than 40% and 30%.
This report is a detailed and comprehensive analysis for global Travelers Vaccines market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by End Users. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Travelers Vaccines market size and forecasts, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (USD/Dose), 2020-2031
Global Travelers Vaccines market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (USD/Dose), 2020-2031
Global Travelers Vaccines market size and forecasts, by Type and by End Users, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (USD/Dose), 2020-2031
Global Travelers Vaccines market shares of main players, shipments in revenue ($ Million), sales quantity (K Doses), and ASP (USD/Dose), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Travelers Vaccines
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Travelers Vaccines market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GlaxoSmithKline, Sanofi Pasteur, Merck, Pfizer, CNBG, Sanofi Pasteur MSD, Serum Institute of India, Biokangtai, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Travelers Vaccines market is split by Type and by End Users. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by End Users in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Meningococcal Vaccine
Japanese Encephalitis Vaccine
Yellow Fever Vaccine
Hepatitis Vaccine
Cholera Vaccine
Other
Market segment by End Users
Tourists
Students
Workers
Others
Major players covered
GlaxoSmithKline
Sanofi Pasteur
Merck
Pfizer
CNBG
Sanofi Pasteur MSD
Serum Institute of India
Biokangtai
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Travelers Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Travelers Vaccines, with price, sales quantity, revenue, and global market share of Travelers Vaccines from 2020 to 2025.
Chapter 3, the Travelers Vaccines competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Travelers Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by End Users, with sales market share and growth rate by Type, by End Users, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Travelers Vaccines market forecast, by regions, by Type, and by End Users, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Travelers Vaccines.
Chapter 14 and 15, to describe Travelers Vaccines sales channel, distributors, customers, research findings and conclusion.
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body"s immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
Travelers are at increased risk for several infections, including familiar infections such as measles that are widely distributed but more common in developing countries. Travelers Vaccines can markedly decrease the risk for many of these infections and are an important part of pretravel preparation.
In this report, the travelers vaccines mainly covers vaccine for hepatitis A, hepatitis B, rabies, typhoid fever, yellow fever, Japanese encephalitis, meningococcal meningitis, cholera, etc.
Merck, GlaxoSmithKline and Sanofi Pasteur are the main manufacturers in the vaccine market, with a market share of more than 60% and a high degree of market concentration. North America and Europe are the main production regions, with market share of more than 40% and 30%.
This report is a detailed and comprehensive analysis for global Travelers Vaccines market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by End Users. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Travelers Vaccines market size and forecasts, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (USD/Dose), 2020-2031
Global Travelers Vaccines market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (USD/Dose), 2020-2031
Global Travelers Vaccines market size and forecasts, by Type and by End Users, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (USD/Dose), 2020-2031
Global Travelers Vaccines market shares of main players, shipments in revenue ($ Million), sales quantity (K Doses), and ASP (USD/Dose), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Travelers Vaccines
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Travelers Vaccines market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GlaxoSmithKline, Sanofi Pasteur, Merck, Pfizer, CNBG, Sanofi Pasteur MSD, Serum Institute of India, Biokangtai, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Travelers Vaccines market is split by Type and by End Users. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by End Users in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Meningococcal Vaccine
Japanese Encephalitis Vaccine
Yellow Fever Vaccine
Hepatitis Vaccine
Cholera Vaccine
Other
Market segment by End Users
Tourists
Students
Workers
Others
Major players covered
GlaxoSmithKline
Sanofi Pasteur
Merck
Pfizer
CNBG
Sanofi Pasteur MSD
Serum Institute of India
Biokangtai
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Travelers Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Travelers Vaccines, with price, sales quantity, revenue, and global market share of Travelers Vaccines from 2020 to 2025.
Chapter 3, the Travelers Vaccines competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Travelers Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by End Users, with sales market share and growth rate by Type, by End Users, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Travelers Vaccines market forecast, by regions, by Type, and by End Users, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Travelers Vaccines.
Chapter 14 and 15, to describe Travelers Vaccines sales channel, distributors, customers, research findings and conclusion.
Table of Contents
102 Pages
- 1 Market Overview
- 2 Manufacturers Profiles
- 3 Competitive Environment: Travelers Vaccines by Manufacturer
- 4 Consumption Analysis by Region
- 5 Market Segment by Type
- 6 Market Segment by End Users
- 7 North America
- 8 Europe
- 9 Asia-Pacific
- 10 South America
- 11 Middle East & Africa
- 12 Market Dynamics
- 13 Raw Material and Industry Chain
- 14 Shipments by Distribution Channel
- 15 Research Findings and Conclusion
- 16 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
